Cipla Limited Stock price

Equities

CIPLA

INE059A01026

Pharmaceuticals

Market Closed - NSE India S.E. 06:43:36 2024-03-01 am EST 5-day change 1st Jan Change
1,471 INR -0.64% Intraday chart for Cipla Limited +0.31% +18.02%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 258B 3.12B Sales 2025 * 281B 3.39B Capitalization 1,195B 14.42B
Net income 2024 * 41.41B 500M Net income 2025 * 45.08B 544M EV / Sales 2024 * 4.37 x
Net cash position 2024 * 66.41B 802M Net cash position 2025 * 95.28B 1.15B EV / Sales 2025 * 3.92 x
P/E ratio 2024 *
29 x
P/E ratio 2025 *
26.5 x
Employees 32,323
Yield 2024 *
0.57%
Yield 2025 *
0.61%
Free-Float 64.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.31%
1 week+0.64%
Current month-0.31%
1 month+6.35%
3 months+22.40%
6 months+18.50%
Current year+18.41%
More quotes
1 week
1 451.40
Extreme 1451.4
1 494.00
1 month
1 385.00
Extreme 1385
1 494.00
Current year
1 252.10
Extreme 1252.1
1 494.00
1 year
852.00
Extreme 852
1 494.00
3 years
738.10
Extreme 738.1
1 494.00
5 years
355.30
Extreme 355.3
1 494.00
10 years
355.30
Extreme 355.3
1 494.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 15-09-30
Director of Finance/CFO - 22-08-15
Chief Tech/Sci/R&D Officer - 85-12-31
Members of the board TitleAgeSince
Director/Board Member 72 13-07-15
Chairman 87 72-07-20
Director/Board Member 83 77-08-15
More insiders
Date Price Change Volume
24-03-01 1,471 -0.64% 1 982 189
24-02-29 1,480 +0.23% 4,923,680
24-02-28 1,477 -0.70% 1,083,605
24-02-27 1,487 +1.20% 1,231,196
24-02-26 1,470 +0.24% 898,290

Delayed Quote NSE India S.E., March 01, 2024 at 01:52 am EST

More quotes
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
1,480 INR
Average target price
1,432 INR
Spread / Average Target
-3.28%
Consensus
  1. Stock
  2. Equities
  3. Stock Cipla Limited - NSE India S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW